Basics Xilio Therapeutics, Inc. Common Stock IPO Date: October 18, 2021 Sector: Healthcare Industry: Biotech Market Cap: $38.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.93% Avg Daily Range (30 D): $0.02 | 2.82% Avg Daily Range (90 D): $0.02 | 2.88% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 293 Avg Trade Size (Sh.) (30 D): 384 Avg Trade Size (Sh.) (90 D): 393 Institutional Trades Total Inst.Trades: 18 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.69M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 597.56K     News Oct 3, 2025 @ 1:00 PM Xilio Therapeutics Announces Upcoming Presentation... Source: Xilio Therapeutics Jun 5, 2025 @ 10:38 PM Xilio Therapeutics Announces Closing of $50.0 Mill... Source: N/A Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire May 31, 2025 @ 12:00 PM Xilio Therapeutics Announces Updated Phase 2 Data ... Source: N/A Mar 11, 2025 @ 11:30 AM Xilio Therapeutics Announces Pipeline and Business... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.61 $-.11 $-.16 Diluted EPS $-.61 $-.11 $-.16 Revenue $ 31.8M $ 19.07M $ 8.08M Gross Profit $ $ $ Net Income / Loss $ -58.49M $ -16.29M $ -15.84M Operating Income / Loss $ -43.78M $ -1.93M $ -14.37M Cost of Revenue $ $ $ Net Cash Flow $ 42.53M $ -17.78M $ 32.48M PE Ratio